BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report) was the target of a significant increase in short interest in July. As of July 15th, there was short interest totalling 14,600 shares, an increase of 47.5% from the June 30th total of 9,900 shares. Based on an average trading volume of 46,200 shares, the short-interest ratio is presently 0.3 days.
BetterLife Pharma Stock Performance
OTCMKTS:BETRF traded down $0.00 during trading hours on Monday, hitting $0.10. The company had a trading volume of 36,000 shares, compared to its average volume of 31,967. BetterLife Pharma has a 52 week low of $0.03 and a 52 week high of $0.15. The stock has a 50-day moving average price of $0.10 and a 200 day moving average price of $0.08.
BetterLife Pharma (OTCMKTS:BETRF – Get Free Report) last released its quarterly earnings results on Thursday, June 27th. The company reported ($0.01) earnings per share for the quarter.
BetterLife Pharma Company Profile
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
Featured Stories
- Five stocks we like better than BetterLife Pharma
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- Investing In Preferred Stock vs. Common Stock
- Leading Gold Stock Shines With Q2 2024 Earnings Release
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Pharma Giant’s Shares Up After Impressive Q2 Earnings Release
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
